{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:49:54Z","timestamp":1792226994679,"version":"4.4.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi240559-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Little nationally representative research has examined Papanicolaou testing rates from before the pandemic in 2019 through the COVID-19 pandemic in 2022. Papanicolaou testing rates among rural females are a concern as they have historically had lower screening rates than their urban counterparts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240559-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the receipt of a Papanicolaou test in the past year among US females overall and females residing in rural and urban areas in 2019, 2020, and 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240559-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This repeated cross-sectional study used data from 3 years of the Health Information National Trends Survey (HINTS), a nationally representative survey that asks respondents about cancer screenings, sources of health information, and health and health care technologies. Study participants were females aged 21 to 65 years. Individuals who received a Papanicolaou test more than 1 to 3 years prior to a HINTS interview were excluded as they were likely not due for a Papanicolaou test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240559-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Survey year (2019, 2020, and 2022) and rural or urban residence were the main exposure variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240559-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Self-reported receipt of a Papanicolaou test within the past year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240559-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 188\u202f243\u202f531 (weighted; 3706 unweighted) females included in the analysis, 12.5% lived in rural areas and 87.5% in urban areas. Participants had a mean (SE) age of 43.7 (0.27) years and were of Hispanic (18.8%), non-Hispanic Asian (5.2%), non-Hispanic Black (12.2%), non-Hispanic White (59.6%), or non-Hispanic other (4.1%) race and ethnicity. In 2022, unadjusted past-year Papanicolaou testing rates were significantly lower among rural vs urban residents (48.6% [95% CI, 39.2%-58.1%] vs 64.0% [95% CI, 60.0%-68.0%];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Adjusted odds of past-year Papanicolaou testing were lower in 2022 than 2019 (odds ratio, 0.70; 95% CI, 0.52-0.95;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240559-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This repeated cross-sectional study found that past-year Papanicolaou testing rates were lower in 2022 than 2019, pointing to a need to increase access to screenings to prevent an uptick in cervical cancer incidence. Rural-vs-urban differences in 2022 indicate a need to specifically target rural females.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.17094","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:31:35Z","timestamp":1718364695000},"page":"e2417094","source":"Crossref","is-referenced-by-count":35,"title":["Cervical Cancer Screening Rates Among Rural and Urban Females, From 2019 to 2022"],"prefix":"10.1001","volume":"7","author":[{"given":"Tyrone F.","family":"Borders","sequence":"first","affiliation":[{"name":"Center for Health Services Research, University of Kentucky, Lexington"},{"name":"College of Nursing, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Thaxton Wiggins","sequence":"additional","affiliation":[{"name":"College of Nursing, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"6","key":"zoi240559r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.15490","article-title":"Changes in cancer screening in the US during the COVID-19 pandemic.","volume":"5","author":"Fedewa","year":"2022","journal-title":"JAMA Netw Open"},{"key":"zoi240559r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106596","article-title":"Impact of COVID-19 on cervical cancer screening: challenges and opportunities to improving resilience and reduce disparities.","volume":"151","author":"Wentzensen","year":"2021","journal-title":"Prev Med"},{"key":"zoi240559r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106559","article-title":"COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.","volume":"151","author":"DeGroff","year":"2021","journal-title":"Prev Med"},{"issue":"6","key":"zoi240559r5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.whi.2017.09.008","article-title":"Urban\/rural differences in breast and cervical cancer incidence: the mediating roles of socioeconomic status and provider density.","volume":"27","author":"Moss","year":"2017","journal-title":"Womens Health Issues"},{"issue":"1","key":"zoi240559r6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10900-011-9439-6","article-title":"Rural-urban trends and patterns in cervical cancer mortality, incidence, stage, and survival in the United States, 1950-2008.","volume":"37","author":"Singh","year":"2012","journal-title":"J Community Health"},{"key":"zoi240559r7","doi-asserted-by":"publisher","DOI":"10.5888\/pcd16.180447","article-title":"Rural\u2013urban and racial\/ethnic disparities in invasive cervical cancer incidence in the United States, 2010-2014.","volume":"16","author":"Yu","year":"2019","journal-title":"Prev Chronic Dis"},{"issue":"11","key":"zoi240559r8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1158\/1055-9965.EPI-17-0430","article-title":"Rural\u2013urban differences in cancer incidence and trends in the United States.","volume":"27","author":"Zahnd","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi240559r9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/jrh.v38.2","article-title":"Rural-urban differences in HPV testing for cervical cancer screening.","volume":"38","author":"Locklar","year":"2022","journal-title":"J Rural Health"},{"issue":"5","key":"zoi240559r10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/19371918.2017.1289872","article-title":"Comparing rural and urban cervical and breast cancer screening rates in a privately insured population.","volume":"32","author":"Orwat","year":"2017","journal-title":"Soc Work Public Health"},{"issue":"4","key":"zoi240559r11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/jrh.v39.4","article-title":"The COVID-19 pandemic impact on independent and provider-based rural health clinics\u2019 operations and cancer prevention and screening provision in the United States.","volume":"39","author":"Zahnd","year":"2023","journal-title":"J Rural Health"},{"issue":"6","key":"zoi240559r12","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1200\/OP.21.00658","article-title":"Cancer screening among rural and urban clinics during COVID-19: a multistate qualitative study.","volume":"18","author":"Hanna","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"7","key":"zoi240559r13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"zoi240559r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8373","article-title":"Overuse of cervical cancer screening tests among women with average risk in the United States from 2013 to 2014.","volume":"4","author":"Wright","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi240559r16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ije\/dyz083","article-title":"Data resource profile: the National Cancer Institute\u2019s Health Information National Trends Survey (HINTS).","volume":"49","author":"Finney Rutten","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"4","key":"zoi240559r18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"123","key":"zoi240559r19","first-page":"37246","article-title":"2010 Standards for delineating metropolitan and micropolitan statistical areas.","volume":"75","author":"Office of Management and Budget","year":"2010","journal-title":"Fed Regist"},{"issue":"6","key":"zoi240559r20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/aje\/kwn411","article-title":"Estimation of the relative excess risk due to interaction and associated confidence bounds.","volume":"169","author":"Richardson","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"2","key":"zoi240559r21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/09691413211001097","article-title":"Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.","volume":"28","author":"Burger","year":"2021","journal-title":"J Med Screen"},{"issue":"5","key":"zoi240559r22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1188\/21.CJON.S1.10-16","article-title":"Rural cancer disparities: understanding implications for breast and cervical cancer diagnoses.","volume":"25","author":"Carnahan","year":"2021","journal-title":"Clin J Oncol Nurs"},{"key":"zoi240559r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106400","article-title":"Cervical cancer screening in the United States: challenges and potential solutions for underscreened groups.","volume":"144","author":"Fuzzell","year":"2021","journal-title":"Prev Med"},{"issue":"9","key":"zoi240559r24","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.2487","article-title":"Trends in US health insurance coverage during the COVID-19 pandemic.","volume":"2","author":"Bundorf","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"6","key":"zoi240559r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.1632","article-title":"Comparison of unemployment-related health insurance coverage changes in Medicaid expansion vs nonexpansion states during the COVID-19 pandemic.","volume":"3","author":"Benitez","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"1","key":"zoi240559r26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1377\/hlthaff.2021.01000","article-title":"Personalized telephone outreach increased health insurance take-up for hard-to-reach populations, but challenges remain.","volume":"41","author":"Myerson","year":"2022","journal-title":"Health Aff (Millwood)"},{"key":"zoi240559r3","unstructured":"Mast? C, Munoz del Rio? A. Delayed cancer screenings: a second look. 2020. Accessed April 8, 2024. https:\/\/epicresearchblob.blob.core.windows.net\/cms-uploads\/pdfs\/Delayed-Cancer-Screenings-Second-Look.pdf"},{"key":"zoi240559r15","unstructured":"Johns Hopkins University Medicine. Coronavirus resource center. Accessed April 2, 2024. https:\/\/coronavirus.jhu.edu\/region\/united-states"},{"key":"zoi240559r17","unstructured":"National Cancer Institute. HINTS\u00ae survey instruments. Accessed March 21, 2024. https:\/\/hints.cancer.gov\/data\/survey-instruments.aspx"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2820025\/borders_2024_oi_240559_1717774236.88842.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:31:43Z","timestamp":1718364703000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2820025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.17094","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}